A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.
Ann Oncol
; 26(2): 422-8, 2015 Feb.
Article
in En
| MEDLINE
| ID: mdl-25403589
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Models, Statistical
/
Clinical Trials, Phase I as Topic
/
Maximum Tolerated Dose
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Ann Oncol
Year:
2015
Document type:
Article